Zuluaga-Sanchez, Santiago http://orcid.org/0000-0003-2840-6996
Teynor, Megan
Knight, Christopher http://orcid.org/0000-0001-6428-0505
Thompson, Robin
Lundqvist, Thomas
Ekelund, Mats
Forsmark, Annabelle http://orcid.org/0000-0001-7804-4810
Vickers, Adrian D. http://orcid.org/0000-0003-0304-1951
Lloyd, Andrew http://orcid.org/0000-0002-7597-6556
Funding for this research was provided by:
Biogen Idec
Article History
First Online: 4 February 2019
Compliance with Ethical Standards
:
: Open access fees were funded by Biogen Inc. This study was funded by Biogen Inc.
: Santiago Zuluaga Sanchez, Christopher Knight and Adrian D. Vickers are full-time employees of RTI Health Solutions, which received funding from Biogen Inc. to conduct this study. The contract between RTI Health Solutions and the sponsor includes independent publication rights. RTI Health Solutions conducts work for the government, public and private organisations, including pharmaceutical companies. Robin Thompson, Thomas Lundqvist and Mats Ekelund are employees of Biogen Inc. Megan Teynor is a former employee of Biogen Inc. Annabelle Forsmark is a full-time employee of Nordic Health Economics AB, which received funding from Biogen Inc. for contributing to this study. Nordic Health Economics AB conducts work involving health economics and outcomes research for the government, public and private sectors. Andrew Lloyd is a Director of Acaster Lloyd Consulting Ltd, which received funding from Biogen Inc. for work that supported the modelling exercise.
: The model generated during the current study is not publicly available because it includes patient-level data from the ENDEAR and CHERISH clinical trials that could be deanonymized.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Informed consent procedures were not applicable to this study.